Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Miller
R Vile

Showing results (1-10 of 1,887) with videos related to

Pageof 189
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 1995
Targeted vectors for gene therapyN Miller, R Vile
Gene Therapy|September 1, 1994
A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genesR Vile, N Miller, Y Chernajovsky, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2011
Selectable markers for eukaryotic cellsR Vile
The Journal of Gene Medicine|May 16, 2000
Cancer gene therapy--new approaches to tumour cell killingR Vile
Current Biology : CB|January 1, 1995
Cancer therapy. Less blood means more sanguinityR Vile
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2011
The retroviral life cycle and the molecular construction of retrovirus vectorsR Vile
BMJ (Clinical Research Ed.)|May 20, 1989
Tumour suppressor genesR Vile
Current Biology : CB|May 1, 1997
Hitting cancer where it hurtsK Sunassee, R Vile
Gene Therapy|March 1, 1994
Gene transfer technologies for the gene therapy of cancerR Vile, S J Russell
Gene Therapy|June 1, 1997
Euro targeting in Leiden: the fourth meeting of the EWGT, University of Leiden, 14-17 November 1996R M Diaz, R Vile
Pageof 189

Showing results (1-10 of 1,887) with videos related to

Sort By:
Pageof 189
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 1995
Targeted vectors for gene therapyN Miller, R Vile
Gene Therapy|September 1, 1994
A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genesR Vile, N Miller, Y Chernajovsky, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2011
Selectable markers for eukaryotic cellsR Vile
The Journal of Gene Medicine|May 16, 2000
Cancer gene therapy--new approaches to tumour cell killingR Vile
Current Biology : CB|January 1, 1995
Cancer therapy. Less blood means more sanguinityR Vile
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2011
The retroviral life cycle and the molecular construction of retrovirus vectorsR Vile
BMJ (Clinical Research Ed.)|May 20, 1989
Tumour suppressor genesR Vile
Current Biology : CB|May 1, 1997
Hitting cancer where it hurtsK Sunassee, R Vile
Gene Therapy|March 1, 1994
Gene transfer technologies for the gene therapy of cancerR Vile, S J Russell
Gene Therapy|June 1, 1997
Euro targeting in Leiden: the fourth meeting of the EWGT, University of Leiden, 14-17 November 1996R M Diaz, R Vile
Pageof 189